AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS : vimarsa

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2022. Key results include: Total revenues increased 6% to $6.2...

Related Keywords

United Kingdom , United States , Puerto Rico , Japan , Japanese , Americans , American , Jessica Akopyan , Roberta Bradway , Provention Bio , Revenue Service , Amgen , Tax Court , American Society Of Clinical Oncology , Healthy Society , Research Development , Astrazeneca , Therapeutics Inc , Arrakis Therapeutics Inc , Teneobio Inc , Repatha On China National Reimbursement Drug List , Kyowa Kirin Co Ltd , Regeneron Pharmaceuticals Inc , American Academy Of Dermatology Association , Amgen Foundation Inc , Plexium Inc , Beigene Ltd , Alexion Pharmaceuticals Inc , American Academy Of Allergy , Exchange Commission , Biomedicines Inc , American Association For Cancer Research , Amgen Inc , Company Puerto Rico , Us Tax Court , Amgen Foundation , Amgen Safety Net Foundation , Internal Revenue Service , National Reimbursement Drug List , Average Selling Price , Sales Detail , Operating Margin , Tax Rate , Operating Expenses , Rodeo Therapeutics , Accelerated Stock Repurchase , Diluted Shares , Income Taxes , Quarter Product , American Academy , Immunology Annual , Black Americans , Dermatology Association , American Association , Cancer Research , American Society , Clinical Oncology , Revolution Medicines , Governance Report Released , Amgen Safety Net , Safety Net Foundation , Wholesale Acquisition , Janssen Pharmaceutica , Regeneron Pharmaceuticals , Alexion Pharmaceuticals , Accepted Accounting Principles , Free Cash Flow , Dow Jones Industrial Average , Best Workplaces , Great Place , Generate Biomedicines , Arrakis Therapeutics , Five Prime Therapeutics , Balance Sheets , Year Ending December , Rate Guidance ,